JP Stock MarketDetailed Quotes

Chugai Pharmaceutical (4519)

Watchlist
  • 8245.0
  • +129.0+1.59%
20min DelayMarket Closed May 1 15:30 JST
13.84TMarket Cap31.26P/E (Static)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Chugai Pharmaceutical (4519) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
Total revenue
11.54%321.75B
7.46%1.26T
21.74%288.46B
5.33%1.17T
18.13%315.91B
-24.11%236.95B
-11.78%1.11T
-37.56%273.81B
14.48%257.9B
13.50%267.42B
Cost of revenue
5.66%92.79B
7.15%363.69B
20.39%87.82B
-17.88%339.41B
-4.06%87.94B
-51.79%72.95B
-13.22%413.31B
-56.76%92.06B
13.26%78.26B
14.83%91.66B
Gross profit
14.12%228.96B
7.59%894.25B
22.34%200.64B
19.07%831.2B
29.71%227.97B
1.92%164B
-10.90%698.06B
-19.43%181.75B
15.02%179.64B
12.82%175.76B
Operating expense
9.70%70.19B
2.15%295.42B
-0.22%63.99B
11.71%289.2B
10.31%69.65B
2.41%64.13B
3.49%258.89B
-20.94%60.18B
23.02%72.96B
13.06%63.14B
Selling and administrative expenses
24.37%28.9B
5.78%116.46B
2.88%23.24B
-2.20%110.1B
-17.88%27.32B
7.47%22.59B
12.05%112.58B
0.02%30.76B
15.82%27.54B
43.65%33.26B
-Selling and marketing expense
24.37%28.9B
5.78%116.46B
2.88%23.24B
-2.20%110.1B
-17.88%27.32B
7.47%22.59B
12.05%112.58B
0.02%30.76B
15.82%27.54B
43.65%33.26B
Research and development costs
2.35%41.89B
3.39%187.6B
-1.03%40.93B
3.76%181.44B
-3.66%42.94B
-3.53%41.36B
16.87%174.87B
-7.46%41.86B
24.15%45.57B
31.79%44.57B
Other operating expenses
-234.83%-596M
-269.43%-8.64B
-196.22%-178M
91.81%-2.34B
95.90%-603M
114.59%185M
-44,726.56%-28.56B
-9,817.97%-12.44B
86.53%-160M
-1,203.82%-14.69B
Operating profit
16.18%158.77B
10.49%598.83B
36.82%136.65B
23.41%542B
40.59%158.32B
1.60%99.87B
-17.65%439.17B
-18.66%121.58B
10.11%106.69B
12.68%112.62B
Net non-operating interest income (expenses)
274.21%1.43B
-199.42%-1.03B
-5,580.00%-822M
-77.79%1.03B
-65.22%480M
-98.90%15M
51,733.33%4.65B
311.79%1.11B
142.48%788M
78.53%1.38B
Non-operating interest income
1,300.00%42M
----
-80.00%3M
--5M
-65.44%480M
-98.90%15M
----
----
----
76.27%1.39B
Non-operating interest expense
----
--207M
--825M
----
----
----
-55.74%27M
-50.00%8M
-53.33%7M
-40.00%9M
Total other finance cost
---1.39B
179.75%819M
----
78.03%-1.03B
----
----
-8,888.46%-4.67B
-320.00%-1.12B
-143.21%-795M
----
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
Other non-operating income (expenses)
Income before tax
17.94%160.2B
10.09%597.81B
35.98%135.83B
22.35%543.03B
39.31%158.8B
0.23%99.89B
-16.44%443.82B
-17.78%122.69B
13.09%107.48B
13.19%113.99B
Income tax
16.02%44.78B
5.19%163.79B
51.42%38.6B
31.57%155.72B
52.40%46.94B
-2.57%25.49B
-24.49%118.35B
-32.64%31.48B
9.80%29.9B
8.70%30.8B
Net income
18.70%115.42B
12.06%434.01B
30.69%97.23B
19.00%387.32B
34.46%111.86B
1.23%74.4B
-13.08%325.47B
-11.00%91.21B
14.42%77.57B
14.94%83.19B
Net income continuous operations
18.70%115.42B
12.06%434.01B
30.69%97.23B
19.00%387.32B
34.46%111.86B
1.23%74.4B
-13.08%325.47B
-11.00%91.21B
14.42%77.57B
14.94%83.19B
Noncontrolling interests
Net income attributable to the company
18.70%115.42B
12.06%434.01B
30.69%97.23B
19.00%387.32B
34.46%111.86B
1.23%74.4B
-13.08%325.47B
-11.00%91.21B
14.42%77.57B
14.94%83.19B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
18.70%115.42B
12.06%434.01B
30.69%97.23B
19.00%387.32B
34.46%111.86B
1.23%74.4B
-13.08%325.47B
-11.00%91.21B
14.42%77.57B
14.94%83.19B
Gross dividend payment
Basic earnings per share
18.68%70.13
12.04%263.73
30.67%59.09
18.99%235.39
34.43%67.98
1.21%45.22
-13.10%197.83
-11.01%55.43
14.41%47.15
14.93%50.57
Diluted earnings per share
18.70%70.13
12.05%263.72
30.68%59.08
18.99%235.36
34.43%67.97
1.21%45.21
-13.08%197.8
-11.00%55.43
14.42%47.14
14.94%50.56
Dividend per share
0
24.49%122
0
22.50%98
2.50%41
0
2.56%80
0.00%40
0
5.26%40
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023
Total revenue 11.54%321.75B7.46%1.26T21.74%288.46B5.33%1.17T18.13%315.91B-24.11%236.95B-11.78%1.11T-37.56%273.81B14.48%257.9B13.50%267.42B
Cost of revenue 5.66%92.79B7.15%363.69B20.39%87.82B-17.88%339.41B-4.06%87.94B-51.79%72.95B-13.22%413.31B-56.76%92.06B13.26%78.26B14.83%91.66B
Gross profit 14.12%228.96B7.59%894.25B22.34%200.64B19.07%831.2B29.71%227.97B1.92%164B-10.90%698.06B-19.43%181.75B15.02%179.64B12.82%175.76B
Operating expense 9.70%70.19B2.15%295.42B-0.22%63.99B11.71%289.2B10.31%69.65B2.41%64.13B3.49%258.89B-20.94%60.18B23.02%72.96B13.06%63.14B
Selling and administrative expenses 24.37%28.9B5.78%116.46B2.88%23.24B-2.20%110.1B-17.88%27.32B7.47%22.59B12.05%112.58B0.02%30.76B15.82%27.54B43.65%33.26B
-Selling and marketing expense 24.37%28.9B5.78%116.46B2.88%23.24B-2.20%110.1B-17.88%27.32B7.47%22.59B12.05%112.58B0.02%30.76B15.82%27.54B43.65%33.26B
Research and development costs 2.35%41.89B3.39%187.6B-1.03%40.93B3.76%181.44B-3.66%42.94B-3.53%41.36B16.87%174.87B-7.46%41.86B24.15%45.57B31.79%44.57B
Other operating expenses -234.83%-596M-269.43%-8.64B-196.22%-178M91.81%-2.34B95.90%-603M114.59%185M-44,726.56%-28.56B-9,817.97%-12.44B86.53%-160M-1,203.82%-14.69B
Operating profit 16.18%158.77B10.49%598.83B36.82%136.65B23.41%542B40.59%158.32B1.60%99.87B-17.65%439.17B-18.66%121.58B10.11%106.69B12.68%112.62B
Net non-operating interest income (expenses) 274.21%1.43B-199.42%-1.03B-5,580.00%-822M-77.79%1.03B-65.22%480M-98.90%15M51,733.33%4.65B311.79%1.11B142.48%788M78.53%1.38B
Non-operating interest income 1,300.00%42M-----80.00%3M--5M-65.44%480M-98.90%15M------------76.27%1.39B
Non-operating interest expense ------207M--825M-------------55.74%27M-50.00%8M-53.33%7M-40.00%9M
Total other finance cost ---1.39B179.75%819M----78.03%-1.03B---------8,888.46%-4.67B-320.00%-1.12B-143.21%-795M----
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
Other non-operating income (expenses)
Income before tax 17.94%160.2B10.09%597.81B35.98%135.83B22.35%543.03B39.31%158.8B0.23%99.89B-16.44%443.82B-17.78%122.69B13.09%107.48B13.19%113.99B
Income tax 16.02%44.78B5.19%163.79B51.42%38.6B31.57%155.72B52.40%46.94B-2.57%25.49B-24.49%118.35B-32.64%31.48B9.80%29.9B8.70%30.8B
Net income 18.70%115.42B12.06%434.01B30.69%97.23B19.00%387.32B34.46%111.86B1.23%74.4B-13.08%325.47B-11.00%91.21B14.42%77.57B14.94%83.19B
Net income continuous operations 18.70%115.42B12.06%434.01B30.69%97.23B19.00%387.32B34.46%111.86B1.23%74.4B-13.08%325.47B-11.00%91.21B14.42%77.57B14.94%83.19B
Noncontrolling interests
Net income attributable to the company 18.70%115.42B12.06%434.01B30.69%97.23B19.00%387.32B34.46%111.86B1.23%74.4B-13.08%325.47B-11.00%91.21B14.42%77.57B14.94%83.19B
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders 18.70%115.42B12.06%434.01B30.69%97.23B19.00%387.32B34.46%111.86B1.23%74.4B-13.08%325.47B-11.00%91.21B14.42%77.57B14.94%83.19B
Gross dividend payment
Basic earnings per share 18.68%70.1312.04%263.7330.67%59.0918.99%235.3934.43%67.981.21%45.22-13.10%197.83-11.01%55.4314.41%47.1514.93%50.57
Diluted earnings per share 18.70%70.1312.05%263.7230.68%59.0818.99%235.3634.43%67.971.21%45.21-13.08%197.8-11.00%55.4314.42%47.1414.94%50.56
Dividend per share 024.49%122022.50%982.50%4102.56%800.00%4005.26%40
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +4.00%
Sample Name
Sample Code
 +2.86%
4
SINOPEC CORP
00386
+2.22%
5
CNOOC
00883
+1.66%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +46.25%
Sample Name
Sample Code
 +33.47%
Sample Name
Sample Code
 +26.48%
4
Loongson Technology Corporation
688047
+24.63%
5
Rockchip Electronics
603893
+19.54%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -